We are live on ! Find out more
IMNM icon

Immunome
IMNM

104 hedge funds and large institutions have $907M invested in Immunome in 2024 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 29 increasing their positions, 11 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

427% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 11

294% more capital invested

Capital invested by funds: $230M → $907M (+$677M)

164% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 11

110% more call options, than puts

Call options by funds: $1.71M | Put options by funds: $816K

82% more funds holding

Funds holding: 57 → 104 (+47)

15.68% more ownership

Funds ownership: 50.32% → 66% (+16%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
104
Holders Change
+47
Holders Change %
+82.46%
% of All Funds
1.5%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
58
Increased
29
Reduced
11
Closed
11
Calls
$1.71M
Puts
$816K
Net Calls
+$896K
Net Calls Change
+$242K

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$30.8M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$24.2M
3
RG
Redmile Group
California
+$20.5M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$19.5M
5
TCM
Tang Capital Management
California
+$14.6M

Top Sellers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
-$9.33M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.54M
3
PCM
Prentice Capital Management
Connecticut
-$1.2M
4
MC
Mayo Clinic
Minnesota
-$1.16M
5
Barclays
Barclays
United Kingdom
-$1.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
TD Asset Management
26
TD Asset Management
Ontario, Canada
$7.05M +$3.22M +158,526 +125%
Ameriprise
27
Ameriprise
Minnesota
$6.51M +$5.35M +263,869 New
ACP
28
Altitude Crest Partners
Connecticut
$6.47M +$5.32M +262,284 New
Primecap Management
29
Primecap Management
California
$5.26M +$4.32M +213,000 New
State Street
30
State Street
Massachusetts
$4.95M +$3.45M +170,100 +556%
Jane Street
31
Jane Street
New York
$4.88M +$1.91M +94,292 +91%
Handelsbanken Fonder
32
Handelsbanken Fonder
Sweden
$4.57M +$3.75M +185,000 New
Balyasny Asset Management
33
Balyasny Asset Management
Illinois
$3.81M +$2.55M +125,839 +439%
Morgan Stanley
34
Morgan Stanley
New York
$3.69M +$2.54M +125,087 +515%
AGM
35
Alpine Global Management
New York
$3.51M -$1.02M -50,036 -26%
Northern Trust
36
Northern Trust
Illinois
$3.34M +$716K +35,260 +35%
Acadian Asset Management
37
Acadian Asset Management
Massachusetts
$3.29M +$2.32M +114,433 +602%
MIM
38
Monashee Investment Management
Massachusetts
$3.27M +$2.69M +132,500 New
EI
39
EAM Investors
California
$3.16M +$2.6M +127,980 New
CAN
40
Cetera Advisor Networks
California
$3.04M +$2.5M +123,098 New
Cetera Investment Advisers
41
Cetera Investment Advisers
Illinois
$3.04M +$2.5M +123,098 New
Squarepoint
42
Squarepoint
New York
$2.96M +$2.43M +119,772 New
Manulife (Manufacturers Life Insurance)
43
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.71M +$1.14M +55,940 +104%
LCM
44
Laurion Capital Management
New York
$2.54M – – –
Cerity Partners
45
Cerity Partners
New York
$1.96M +$363K +17,877 +29%
JGC
46
J. Goldman & Co
New York
$1.93M +$1.59M +78,207 New
ZP
47
Zimmer Partners
New York
$1.85M +$1.52M +75,000 New
CSS
48
Cubist Systematic Strategies
Connecticut
$1.81M +$1.28M +63,292 +618%
Swiss National Bank
49
Swiss National Bank
Switzerland
$1.76M +$1.45M +71,400 New
HF
50
HRT Financial
New York
$1.71M +$1.41M +69,305 New
1
2
3 4 5

IMNM Hedge Fund Activity: Q1 2024 in Review

104 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Immunome (IMNM) for Q1 2024, worth a combined $907M — up 294% from $230M a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new IMNM positions and 11 closed out — a net gain of 47 holders — while 29 added to existing stakes and 11 trimmed.

The largest buyer was T. Rowe Price Investment Management, opening a new position worth an estimated $30.8M. The largest seller was Avidity Partners Management, cutting an estimated $9.33M.

  • 104 institutional investors held Immunome (IMNM) as of Q1 2024, up from 57 in Q4 2023.
  • Funds reported $907M of Immunome stock for Q1 2024, up 294% quarter-over-quarter.
  • 58 funds opened new Immunome positions in Q1 2024 and 11 closed out, a net change of +47 holders.
  • The largest Immunome buyer in Q1 2024 was T. Rowe Price Investment Management, an estimated $30.8M added.
  • The largest Immunome seller in Q1 2024 was Avidity Partners Management, an estimated $9.33M sold.

Based on aggregated 13F filings for Q1 2024.